NeuroControl Vocare bladder/bowel control implant trials to begin in coming weeks.
This article was originally published in The Gray Sheet
Executive SummaryNEUROCONTROL VOCARE BLADDER/BOWEL CONTROL IMPLANT PATIENT ENROLLMENT in U.S. clinicals is expected to begin in the next several weeks pending institutional review board approval at the clinical study sites, the company says. IRB submissions for The Vocare Bladder System, which is designed to restore bladder and bowel function in patients with injured spinal cords, are pending at five U.S. centers in the U.S. NeuroControl Corp. is hoping that study implants will begin in June after baseline data is gathered for enrolled patients.
You may also be interested in...
Can shaving ever be “friction free”? Not according to Procter & Gamble, which challenged in a complaint to the UK Advertising Standards Authority a claim made by a British cosmetics firm FFS that it provided a “friction free” shaving experience for women via its subscription razor service.
Work has started on UK-only regulations for the medtech and medicines sectors, to ensure that the regulatory framework not only functions but can also react swiftly to needs after the UK leaves the EU. This article is part two of two.